August 9, 2018 5:49pm
Although Q2 the LPS (loss-per-share) earnings has initiated blooming sentiment favoring share price bounce-backs post release
Pre-open indications: 4 hit and 0 miss
Closing numbers as Q2/18 earning’s report: Organovo (ONVO +$0.07), Histogenics (HSGX +$0.10), Asterias Biotherapeutics (NYSEMKT: AST -$0.025), Caladrius Bioscience (CLBS +$0.38), Stemline Therapeutics (STML +$0.80), Intrexon (XON +$0.12) and BioLife Solutions (BLFS - $0.85)
Earnings note: Intrexon (XON) is delaying the filing of its 10-Q. The delay in filing the Q2 report is related to XON's application of certain aspects of ASC 606 in its Q1 Form 10-Q. XON will be filing an amended Form 10-Q for Q1/18 and expects to file the Q2 report and amended Q1 report within the next few days.
How many times, can one be right! Consider these end-of-day results as Friday’s primer.
A “buck” a day keeps your portfolio in the play - should have a subscriber … you could have been reading this now!
My motto, “Never leave an investor uninformed”!
Members only. Please login.